India Diabetes Care Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

The India Diabetes Care Devices Market is segmented into Monitoring Devices (Self-monitoring Blood Glucose, Continuous Glucose Monitoring), and Management Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors), and The report offers the value (in USD million) for the above segments.

Market Snapshot

Indian diabetes devices market Overview
Study Period: 2016-2027
Base Year: 2021
CAGR: >3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The India Diabetes Care Devices Market is expected to register a CAGR greater than 3% over the forecast period, 2022-2027.

According to the Article Published in “THE HINDU” One in six people with diabetes in the world is from India. The numbers place the country among the top 10 countries for people with diabetes, coming in at number two with an estimated 80 million diabetics. Over half of the population in India is at risk of having diabetes at some time in their life, making the disease a significant public health problem. A rise in type 2 diabetes incidence is also being seen in India's rural areas.

High blood sugar levels are a hallmark of the metabolic disorder diabetes mellitus, also known as diabetes. Type 1 diabetes or insulin-dependent diabetes mellitus is caused by a complete lack of insulin. Type 2 diabetes mellitus is a condition where the body does not produce enough insulin, or the body cannot utilize the insulin it produces. Type 2 diabetes is said to be a lifestyle disease. The consumption of sugary sweets is a staple of Indian culture and an integral part of ancient traditions and religious festivals.

Diabetes care devices are devices used to monitor the glucose levels in the blood. The main types of diabetes care devices include glucose monitoring devices and management devices. Continuous glucose monitoring devices have become immensely popular due to the rise in technological innovations. India holds the second-largest market in the diabetes care devices market after China in the Asia-Pacific region, because of the increasing diabetes population in the country. The diabetes population in India is expected to reach 92 million by 2027.

Thus, owing to the above factors it is expected to drive the market growth over the forecast period.

Scope of the Report

The India Diabetes Care Devices Market is segmented by Monitoring Devices (Self-monitoring Blood Glucose and Continuous Glucose Monitoring) and by Management Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable pens, Insulin Disposable Pens, and Jet Injectors). The report offers the value (in USD million) for the above segments.

Monitoring Devices
Self-monitoring Blood Glucose Devices (Value and Volume, 2016 - 2027)
Glucometer Devices
Test Strips
Lancets
Continuous Blood Glucose Monitoring (Value and Volume, 2016 - 2027)
Sensors
Durables
Management Devices
Insulin Pump (Value and Volume, 2016 - 2027)
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes (Value and Volume, 2016 - 2027)
Insulin Cartridges (Value and Volume, 2016 - 2027)
Disposable Pens (Value and Volume, 2016 - 2027)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Increasing use of monitoring devices in India

In India Monitoring Devices Segment is expected to increase with a CAGR of over 7 % during the forecast period, mainly due to the demand from the Type-1 diabetes population, which was more than 9 million by the end of 2027.

Monitoring devices include self-monitoring blood glucose (SMBG) and continuous glucose monitoring devices (CGM). The SMBG segment held a major share in the India diabetes devices market and generated a revenue of USD 130.53 million in 2021. The frequency of monitoring glucose levels depends on the type of diabetes, which varies from patient to patient. The awareness of self-monitoring of glucose levels has increased widely in India, and the market for monitoring devices is expected to see high growth in the country with a CAGR of 10% during the forecast period. Type-1 diabetic patients need to check their blood glucose levels at regular intervals to adjust the insulin dosing accordingly. The current CGM devices reduce all the finger pricking for measuring blood glucose levels. It shows a detailed representation of blood glucose patterns and tendencies than what can be achieved by conventional routine checking of glucose levels at set intervals.

Thus, owing to the above factors it is expected to drive the market growth over the forecast period.

India Diabetes Devices Market_trend

India recorded the second-highest diabetes population in Asia-Pacific in 2021

In India currently, there are 80.52 million people suffering from diabetes and by 2027 nearly 10% of India’s population is likely to be affected by diabetes. Obesity, especially central obesity and increased visceral fat due to physical inactivity, and consumption of high-calorie/high-fat and high sugar diets are the major contributing factors to diabetes in Indians. The most prominent work culture perpetuated in the country, which includes sitting for hours in one position and eating fast food with little or no physical activity, is a significant contributor to diabetes in the working-age group, causing this rapid increase in diabetes cases in India.

In India, International Diabetes Federation (IDF) estimates that 10% of global health expenditure is being spent on diabetes. According to the Ministry of Health and Family Welfare Government of India out of all deaths in India, 60% of deaths are related to Non-Communicable Diseases (NCD). Non-Communicable Diseases like Diabetes, Cardiovascular diseases, Cancer, Chronic Respiratory Diseases, etc. In order to prevent and control major NCDs, the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS), this program includes medical education, health awareness in schools, and urban planning of Diabetes.

Thus, owing to the above factors it is expected to drive the market growth over the forecast period.

India Diabetes Population

Competitive Landscape

India Diabetes Care Devices Market is dominated by a few major players. For the CGM market in India, there are only a few players that occupy a major share of the market. However, in the SMBG market, the number of players is high and includes several local players.

Recent Development

In March 2022, Medtronic India launched MiniMed 780G, next-generation closed-loop insulin pump system. The MiniMed 780G system is a next-generation closed-loop insulin pump system for the treatment of type-1 diabetes in people aged 7 – 80 years.

In February 2022, Hyderabad-based BlueSemi startup designed Eyva, a completely non-invasive glucose monitor, has been designed and made in India.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Industry Attractiveness - Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Monitoring Devices

      1. 5.1.1 Self-monitoring Blood Glucose Devices (Value and Volume, 2016 - 2027)

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

      2. 5.1.2 Continuous Blood Glucose Monitoring (Value and Volume, 2016 - 2027)

        1. 5.1.2.1 Sensors

        2. 5.1.2.2 Durables

    2. 5.2 Management Devices

      1. 5.2.1 Insulin Pump (Value and Volume, 2016 - 2027)

        1. 5.2.1.1 Insulin Pump Device

        2. 5.2.1.2 Insulin Pump Reservoir

        3. 5.2.1.3 Infusion Set

      2. 5.2.2 Insulin Syringes (Value and Volume, 2016 - 2027)

      3. 5.2.3 Insulin Cartridges (Value and Volume, 2016 - 2027)

      4. 5.2.4 Disposable Pens (Value and Volume, 2016 - 2027)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2016-2027)

    2. 6.2 Type-2 Diabetes population (2016-2027)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Becton and Dickenson

      2. 7.1.2 Medtronic

      3. 7.1.3 Insulet

      4. 7.1.4 Tandem

      5. 7.1.5 Ypsomed

      6. 7.1.6 Novo Nordisk

      7. 7.1.7 Sanofi

      8. 7.1.8 Eli Lilly

      9. 7.1.9 Abbottt

      10. 7.1.10 Roche

      11. 7.1.11 Lifescan (Johnson &Johnson)

      12. 7.1.12 Dexcom

    2. 7.2 Company Share Analysis

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The India Diabetes Devices Market market is studied from 2016 - 2027.

The India Diabetes Devices Market is growing at a CAGR of >3% over the next 5 years.

The India Diabetes Devices Market is valued at 2016 Million USD in 2016.

The India Diabetes Devices Market is valued at 2415 Million USD in 2027.

Medtronics, Becton Dickinson, Roche, Dexcom, Abbott are the major companies operating in India Diabetes Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!